Cargando…

Urinary active transforming growth factor β in feline chronic kidney disease

The cytokine transforming growth factor beta 1 (TGF-β1) has been widely implicated in the development and progression of renal fibrosis in chronic kidney disease (CKD) in humans and in experimental models. The aims of this study were to assess the association between urinary active TGF-β1 and (a) de...

Descripción completa

Detalles Bibliográficos
Autores principales:	Lawson, J.S., Syme, H.M., Wheeler-Jones, C.P.D., Elliott, J.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Balliere Tindall 2016
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4949776/ https://www.ncbi.nlm.nih.gov/pubmed/27387717 http://dx.doi.org/10.1016/j.tvjl.2016.02.004

Ejemplares similares

Investigation of the transforming growth factor-beta 1 signalling pathway as a possible link between hyperphosphataemia and renal fibrosis in feline chronic kidney disease
por: Lawson, J.S., et al.
Publicado: (2021)

Characterisation of Crandell-Rees Feline Kidney (CRFK) cells as mesenchymal in phenotype
por: Lawson, J.S., et al.
Publicado: (2019)

Characterisation of feline renal cortical fibroblast cultures and their transcriptional response to transforming growth factor β1
por: Lawson, J. S., et al.
Publicado: (2018)

Urinary extracellular vesicles as a source of protein‐based biomarkers in feline chronic kidney disease and hypertension
por: Lawson, J. S., et al.
Publicado: (2022)

Relationship between Plasma Fibroblast Growth Factor‐23 Concentration and Survival Time in Cats with Chronic Kidney Disease
por: Geddes, R.F., et al.
Publicado: (2015)

Risk Factors for Development of Chronic Kidney Disease in Cats
por: Finch, N.C., et al.
Publicado: (2016)

The cat as a naturally occurring model of renal interstitial fibrosis: Characterisation of primary feline proximal tubular epithelial cells and comparative pro-fibrotic effects of TGF-β1
por: Lawson, Jack S., et al.
Publicado: (2018)

Aldosterone and the mineralocorticoid receptor in renal injury: A potential therapeutic target in feline chronic kidney disease
por: Spencer, Sarah, et al.
Publicado: (2020)

Plasma N‐Terminal Probrain Natriuretic Peptide, Vascular Endothelial Growth Factor, and Cardiac Troponin I as Novel Biomarkers of Hypertensive Disease and Target Organ Damage in Cats
por: Bijsmans, E.S., et al.
Publicado: (2017)

Serum Cystatin C Concentrations in Cats with Hyperthyroidism and Chronic Kidney Disease
por: Williams, T.L., et al.
Publicado: (2016)

Profibrotic effects of angiotensin II and transforming growth factor beta on feline kidney epithelial cells
por: van Beusekom, Cyrina D, et al.
Publicado: (2018)

Renal Senescence, Telomere Shortening and Nitrosative Stress in Feline Chronic Kidney Disease
por: Quimby, Jessica, et al.
Publicado: (2021)

Changes in Systolic Blood Pressure over Time in Healthy Cats and Cats with Chronic Kidney Disease
por: Bijsmans, E.S., et al.
Publicado: (2015)

Psychometric Validation of a General Health Quality of Life Tool for Cats Used to Compare Healthy Cats and Cats with Chronic Kidney Disease
por: Bijsmans, E.S., et al.
Publicado: (2016)

Association of urinary transforming growth factor-β1 with the ureteropelvic junction obstruction
por: Merrikhi, Alireza, et al.
Publicado: (2014)

Urinary monocyte chemotactic protein-1 and transforming growth factor-β in systemic lupus erythematosus
por: Torabinejad, S., et al.
Publicado: (2012)

Expression of transforming growth factor-β (TGF-β) in chronic idiopathic cough
por: Xie, Shaoping, et al.
Publicado: (2009)

Effective prediction of preeclampsia by measuring serum angiotensin II, urinary angiotensinogen and urinary transforming growth factor β1
por: Zhang, Lihong, et al.
Publicado: (2017)

Transforming growth factor-β and breast cancer: Tumor promoting effects of transforming growth factor-β
por: Dumont, Nancy, et al.
Publicado: (2000)

Case-Control Study of Risk Factors Associated with Feline and Canine Chronic Kidney Disease
por: Bartlett, Paul C., et al.
Publicado: (2010)

Comparison of Efficacy of Long‐term Oral Treatment with Telmisartan and Benazepril in Cats with Chronic Kidney Disease
por: Sent, U., et al.
Publicado: (2015)

Transforming growth factor-β and breast cancer: Transforming growth factor-β/SMAD signaling defects and cancer
por: Kretzschmar, Marcus
Publicado: (2000)

Influence of chylomicron remnants on human monocyte activation in vitro
por: Bentley, C., et al.
Publicado: (2011)

Transforming growth factor beta (TGF-β) in adolescent chronic fatigue syndrome
por: Wyller, Vegard Bruun, et al.
Publicado: (2017)

Renal shear wave elastography and urinary procollagen type III amino-terminal propeptide (uPIIINP) in feline chronic kidney disease
por: Thanaboonnipat, Chutimon, et al.
Publicado: (2019)

Markers of Angiogenesis Associated with Surgical Attenuation of Congenital Portosystemic Shunts in Dogs
por: Tivers, M.S., et al.
Publicado: (2014)

Circulating transforming growth factor-β1 levels and the risk for kidney disease in African-Americans
por: Suthanthiran, Manikkam, et al.
Publicado: (2009)

An Update on Feline Chronic Gingivostomatitis
por: Lee, Da Bin, et al.
Publicado: (2020)

Transforming growth factor–β in tissue fibrosis
por: Frangogiannis, Nikolaos G.
Publicado: (2020)

Transforming growth factor-β in tumour development
por: Trelford, Charles B., et al.
Publicado: (2022)

SUN-552 Follistatin-Like 3 (FSTL3), a Transforming Growth Factor β (TGFβ) Ligand Inhibitor, Regulates Placental Development in Mice
por: Huntington, Josef, et al.
Publicado: (2020)

Low temperature compartment formation in feline immunodeficiency virus-infected and uninfected feline kidney cells
por: Morré, D. J., et al.
Publicado: (1993)

Transforming growth factor-β and breast cancer: Cell cycle arrest by transforming growth factor-β and its disruption in cancer
por: Donovan, Jeffrey, et al.
Publicado: (2000)

Transforming growth factor-β1 in plaque morphea
por: Dańczak-Pazdrowska, Aleksandra, et al.
Publicado: (2013)

Genetic dominance of transforming growth factor-β1 polymorphisms in chronic liver disease
por: Cai, Xuanyan, et al.
Publicado: (2022)

Effect on Renal Function of Restoration of Euthyroidism in Hyperthyroid Cats with Iatrogenic Hypothyroidism
por: Williams, T.L., et al.
Publicado: (2014)

Plasma Renin Activity and Aldosterone Concentrations in Hypertensive Cats with and without Azotemia and in Response to Treatment with Amlodipine Besylate
por: Jepson, R.E., et al.
Publicado: (2013)

Feline Morbillivirus, a New Paramyxovirus Possibly Associated with Feline Kidney Disease
por: Choi, Eun Jin, et al.
Publicado: (2020)

Detection of feline idiopathic cystitis as the cause of feline lower urinary tract disease in Sleman Regency, Indonesia
por: Astuty, Andi Tri Julyana Eka, et al.
Publicado: (2020)

De-ubiquitinating enzyme, USP11, promotes transforming growth factor β-1 signaling through stabilization of transforming growth factor β receptor II
por: Jacko, A M, et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_ve8p5gi5obn2okboocmqmq142p